Literature DB >> 26452023

Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease.

Diane Kottler1, Stéphane Barète, Gaelle Quéreux, Saskia Ingen-Housz-Oro, Sylvie Fraitag, Nicolas Ortonne, Lydia Deschamps, Michel Rybojad, Béatrice Flageul, Béatrice Crickx, Anne Janin, Martine Bagot, Maxime Battistella.   

Abstract

BACKGROUND: Kimura disease (KD) is a rare lymphoproliferative inflammatory disease of unknown etiology. Data regarding therapeutic modalities and pathophysiology are scarce.
OBJECTIVES: Analyze therapeutic and follow-up data and compare KD with cutaneous IgG4-related disease (IgG4-RD).
METHODS: Multicentric retrospective study of 25 KD patients with analysis of treatment, follow-up and IgG4 immunostaining. Comparison with published cases of cutaneous IgG4-RD.
RESULTS: Patients were mostly male (84%), median-aged 42 years with lymph node, lacrimal/salivary gland and kidney involvements in 45, 24 and 12%, respectively. Surgical excision had 100% complete response and 60% relapse. Oral corticosteroids had 100% response with 50% relapse. Thalidomide, cyclosporine or interferon-α had 100% response, but 100, 20 and 50% relapse, respectively. KD showed clinicopathological similarities with 27 published cases of cutaneous IgG4-RD.
CONCLUSION: Surgery may be used in resectable KD cases, whereas cyclosporine or thalidomide may represent interesting alternatives to oral corticosteroids in other cases. KD shares features with cutaneous IgG4-RD.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26452023     DOI: 10.1159/000439346

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

Review 1.  Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: case report and review of 10 Japanese patients.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Masaru Kinomura
Journal:  J Clin Exp Hematop       Date:  2017

2.  Cervical Recurrence from an Intraparotid Kimura Disease.

Authors:  L Esparza Lasaga; R Bemúdez Cameo; A Valero Torres; E Delso Gil
Journal:  J Maxillofac Oral Surg       Date:  2020-07-09

3.  Treatment of Kimura disease with mycophenolate mofetil monotherapy.

Authors:  Kalee Shah; Anh N Tran; Cynthia M Magro; Julie B Zang
Journal:  JAAD Case Rep       Date:  2017-09-08

4.  Kimura's disease of the parotid gland with cutaneous features in a Caucasian female patient.

Authors:  Natalia Glibbery; Kenneth Muscat; Luke Cascarini
Journal:  J Surg Case Rep       Date:  2018-04-09

5.  Recurrent auricular inflammation caused by Kimura's disease: reminiscent of the early phase of relapsing polychondritis?

Authors:  Toshiki Ito
Journal:  Oxf Med Case Reports       Date:  2019-09-28

6.  Immunohistochemical analysis of pyroptosis-related protein expression in IgG4-related sialadenitis.

Authors:  Jiao Pu; Mengying Jia; Wei Shi; Lulu Hu; Fang Wang; Yaqi Niu; Qiaoying Tong; Zhongcheng Gong
Journal:  J Oral Pathol Med       Date:  2022-03-09       Impact factor: 3.539

7.  Concurrence of IgG4-related disease and Kimura disease with pulmonary embolism and lung cancer: a case report.

Authors:  Ye Lu; Junxiu Liu; Hengyi Yan; Wei Feng; Li Zhao; Yu Chen
Journal:  BMC Pulm Med       Date:  2022-08-09       Impact factor: 3.320

8.  Kimura disease with Allergic Bronchopulmonary Aspergillosis: a case report.

Authors:  Ruiyun Fan; Guopeng Xu; Ying Chen; Jinghuan Lv; Zhongwei Zhang
Journal:  Allergy Asthma Clin Immunol       Date:  2022-06-27       Impact factor: 3.373

9.  Kimura's disease: a rare cause of chronic neck lymphadenopathy.

Authors:  Kenneth Y Y Kok; Edwin C C Lim
Journal:  J Surg Case Rep       Date:  2021-07-19

10.  Kimura Disease: A Rare and Difficult to Diagnose Entity.

Authors:  Clayton Bishop; Alyeesha Wilhelm; Duncan Watley; Felix Olobatuyi; Orly Coblens; Rohan Joshi
Journal:  Head Neck Pathol       Date:  2021-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.